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BeKm-1 Is a HERG-Speciﬁc Toxin that Shares the Structure
with ChTx but the Mechanism of Action with ErgTx1
Mei Zhang,* Yuliya V. Korolkova,y Jie Liu,* Min Jiang,* Eugene V. Grishin,y and Gea-Ny Tseng*
*Department of Physiology, Virginia Commonwealth University, Richmond, Virginia, USA; and
y
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia

ABSTRACT Peptide toxins with disulﬁde-stabilized structures have been used as molecular calipers to probe the outer
vestibule structure of K channels. We want to apply this approach to the human ether-a-go-go-related gene (HERG) channel,
whose outer vestibule is unique in structure and function among voltage-gated K channels. Our focus here is BeKm-1, a HERGspeciﬁc peptide toxin that can suppress HERG in the low nM concentration range. Although BeKm-1 shares the threedimensional scaffold with the well-studied charybdotoxin, the two use different mechanisms in suppressing currents through
their target K channels. BeKm-1 binds near, but not inside, the HERG pore, and it is possible that BeKm-1-bound HERG
channels can conduct currents although with markedly altered voltage-dependence and kinetics of gating. BeKm-1 and ErgTx1
differ in three-dimensional scaffold, but the two share mechanism of action and have overlapping binding sites on the HERG
channel. For both, residues in the middle of the S5-P linker (the putative 583–597 helix) and residues at the pore entrance are
critical for binding, although speciﬁc contact points vary between the two. Toxin foot printing using BeKm-1 and ErgTx1 will likely
provide complementary information about the unique outer vestibule structure of the HERG channel.

INTRODUCTION
Human ether-a-go-go-related gene (HERG) encodes the
pore-forming subunit of the rapid delayed rectiﬁer K (IKr)
channels (Sanguinetti et al., 1995; Trudeau et al., 1995). IKr
plays a key role in maintaining the electrical stability of the
heart (Tseng, 2001). Therefore inherited mutations in HERG,
and more importantly adverse drug effects that suppress IKr
function, are linked to congenital and acquired long QT
syndrome (Roden and Balser, 1999). HERG is also
expressed in noncardiac cell types (Rosati et al., 2000;
Smith et al., 2002; Zhou et al., 1998; Faravelli et al., 1996),
and may play signiﬁcant roles under physiological (e.g.,
insulin secretion in pancreatic b-cells (Rosati et al., 2000)) or
pathological conditions (e.g., cancer cell growth (Smith et al.,
2002)). Therefore, agents that can suppress or enhance the
HERG channel function may ﬁnd important therapeutic
applications other than antiarrhythmic therapy (Roche et al.,
2002). From this point of view, it is essential to obtain
structural information about domains in the HERG channel
that are involved in determining drug binding afﬁnity and
speciﬁcity.
The HERG channel has a broad spectrum of drug
sensitivity (Roden and Balser, 1999). Importantly, drug
sensitivity of this channel seems to be tightly regulated by
conformational changes around the outer mouth region
during membrane depolarization (C-type inactivation (Smith
et al., 1996)) (Wang et al., 1997; Numaguchi et al., 2000;
Ulens and Tytgat, 2000; although see Chen et al., 2002).
Submitted November 14, 2002, and accepted for publication January 28,
2003.
Address reprint requests to Gea-Ny Tseng, PhD, Dept. of Physiology,
Virginia Commonwealth University, 1101 E. Marshall St., Richmond, VA
23298. Tel.: 804-827-0811; Fax: 804-828-7382; E-mail: gtseng@hsc.
vcu.edu.
Ó 2003 by the Biophysical Society
0006-3495/03/05/3022/15 $2.00

Therefore, information about the structure of HERG’s outer
vestibule and pore region and the nature of conformational
changes underlying C-type inactivation is valuable. The
outer vestibule of the HERG channel, as in other K channels,
is lined mainly by loops linking the ﬁfth transmembrane
segment (S5) and the pore region, the S5-P linkers. HERG’s
S5-P linker is unique in that it is 2–3 times the length of S5-P
linkers in other K channels (43 aa vs. 12–23 aa) (Liu et al.,
2002). We have performed cysteine scanning mutagenesis
experiments to probe the structural and functional role of this
linker (residues 571–613) (Liu et al., 2002). The results
suggest that the middle segment of this linker (residues 583–
597) may form an amphipathic a-helix, and is involved not
only in the pore function (C-type inactivation and K1
selectivity) but also in the activation gating process. We
proposed a model in which this a-helix is oriented parallel to
the channel surface, capable of interacting with the pore
entrance at one end and with the voltage-sensing domain at
the other (Liu et al., 2002).
Our next step is to see whether these features can be built
into a model of three-dimensional (3-D) structure. Crystal
structures of K channels’ pore-domains are available: KcsA
crystal structure representing the pore in the closed state, and
MthK crystal structure representing the pore in the open state
(Doyle et al., 1998; Jiang et al., 2002). Homology modeling
using these crystal structures as templates has been applied to
several channels (Rauer et al., 2000; Capener et al., 2000;
Lipkind and Fozzard, 1997). Unfortunately, this approach
cannot be applied to the HERG channel for two reasons. First,
the ‘‘S5-P equivalent’’ in the KcsA or MthK crystal does not
have a well-deﬁned structure (Doyle et al., 1998; Jiang et al.,
2002). Second, the marked differences in the length and
amino acid sequence in this region between HERG and KcsA
or MthK make sequence alignment (a prerequisite for
homology modeling) impossible (see Fig. 11 A).

Scorpion Toxins and HERG Outer Vestibule

Peptide toxins that can bind to the outer vestibule of the
HERG channel will be useful tools to bring us closer to an
understanding of the channel’s structure. Known peptide
toxins that modulate K channel function are usually short
(30–40 aa), and contain three or four disulﬁde bonds (Tytgat
et al., 1999). The reticulation of these disulﬁde bonds makes
the peptide structures compact and rigid, amenable to
structural analysis using NMR spectroscopy and suitable as
‘‘molecular calipers’’ to probe the structures of binding sites
on their target channels (Miller, 1995). Indeed, peptide toxin
‘‘foot printing’’ using strategies such as mutant cycle analysis has been a useful way to deduce the spatial relationships of residues lining the outer vestibule of different
K channels (Hidalgo and MacKinnon, 1995; Miller,
1995). Several HERG-speciﬁc peptide toxins are available:
BeKm-1 (Korolkova et al., 2001), ErgToxin 1 (ErgTx1)
(Gurrola et al., 1999), ErgTx2 (Lecchi et al., 2002), and
CsEKerg1 (Nastainzyk et al., 2002). BeKm-1 belongs to
the a-KTx subfamily, whereas the other three belong to the
g-KTx subfamily (Tytgat et al., 1999) (Fig. 1). Previously
we have shown that ErgTx1 binds to the outer vestibule of
the HERG channel (Pardo-Lopez et al., 2002). The binding
site is probably formed by uncharged residues in the S5-P
and P-S6 linkers of the HERG channel (Pardo-Lopez et al.,
2002). The focus of this study is BeKm-1, whose NMR
structure has been solved recently (Korolkova et al., 2002).
Although BeKm-1 and charybdotoxin (ChTx) share the 3-D
scaffold (Fig. 1 A), there are important differences between
the two. ChTx binds to its target K channels (Maxi-K or Kv
channels such as the Shaker) using the bII surface
(interaction surface), and the lysine residue at position 27
(K27) plays a critical role (Fig. 1 A) (Park and Miller, 1992;
Goldstein and Miller, 1993; Ranganathan et al., 1996). In
a ChTx/Shaker complex, the e-amino group of K27
functions as a ‘‘tethered’’ K1 ion. It protrudes into the
pore, binding near the ‘‘selectivity ﬁlter’’ of the pore and
occluding current ﬂow. BeKm-1 has an arginine at the
equivalent position (R27, Fig. 1 A). The guanidinium moiety
of the arginine side chain is much bulkier than the amino
group of a lysine, and cannot insert into the pore. This is
why the K27R mutation of ChTx reduces its potency by
[1000-fold (Goldstein et al., 1994). Therefore, BeKm-1
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may bind to the HERG channel using a different domain.
Indeed, a recent alanine mutagenesis study suggests that
residues along the a-helix of BeKm-1 are critical for
suppressing HERG (highlighted in Fig. 1 A) (Korolkova
et al., 2002). There is a precedent: TsKapa (a-KTx 4.2) is
selective for small-conductance, apamin-sensitive, Ca-activated K (SK) channels (Castle, 1999). Its interaction surface
consists of the a-helix (K19) and the loop between bI and
the a-helix (R6 and R9) (Fig. 1 A) (Castle, 1999). It is
conceivable that toxins using different domains as their
interaction surface recognize receptors of different conformations, which in turn reﬂect differences in the structure
of these K channels.
We have two main goals in this study: 1), to deduce the
mechanism by which BeKm-1 suppresses the HERG current,
and 2), to explore the BeKm-1 binding site on the HERG
channel using the cysteine scanning mutagenesis approach.
Our data show that BeKm-1 and ErgTx1 share important
features in their interactions with the HERG channel, and the
mechanism differs from the ‘‘pore-plugging’’ mechanism
described for ChTx blockade of the Shaker channel.
Furthermore, the two toxins’ binding sites on the HERG
channel overlap, but likely involve different contact points.
Thus, BeKm-1 and ErgTx1 have different 3-D scaffold
structures but may share similar functional topologies, whereas BeKm-1 and ChTx have similar scaffold structures but
different functional topologies. These data implicate a unique outer vestibule structure of the HERG channel.
MATERIALS AND METHODS
Toxin preparation
The expression and puriﬁcation of BeKm-1 was performed as described
previously (Korolkova et al., 2001). Brieﬂy, BeKm-1 was expressed in the
periplasm of Escherichia coli (HB101) as a fusion protein with two IgGbinding domains (ZZ) of staphylococcal protein A. The HB101 cells were
harvested and lysed by ultrasonication. After ultracentrifugation, BeKm-1
fusion protein in the supernatant was puriﬁed by an IgG-Sepharose 6FF
column (Amersham Pharmacia Biotech, Piscataway, NJ). BeKm-1 was
cleaved from the fusion protein by enterokinase. The recombinant toxin was
puriﬁed from the cleavage mixture by chromatography on a reverse phase
HPLC column (Delta Pak C18 300-A pore, 3.9 3 300 mm, Waters, Milford,
MA), followed by an ODS Ultrasphere column (4.6 3 150 mm, Beckman,

FIGURE 1 (A) Amino acid sequence alignment of BeKm-1 with two other members of
the a-KTx family: charybdotoxin (ChTx) and
TsKapa. Toxin position numbers are listed on
top. Cysteine residues are boxed and connected based on the determined disulﬁde
bridge pattern. Secondary structures are denoted: open horizontal bar (a-helix) and
closed horizontal bars (b-strands, with bI,
bII, and bIII marked below the BeKm-1
sequence). Toxin residues that have been
shown to be critical for binding to target K channels are highlighted by gray shades. (B) The amino acid sequence and disulﬁde bridge pattern of ErgTx1,
a member of the g-KTx family. The isoelectric pH (pI) and net charges at pH 7 are shown to the right of each toxin sequence.
Biophysical Journal 84(5) 3022–3036
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Fullerton, CA). Mass spectrometry veriﬁed the composition of the puriﬁed
material. The toxin peptide content was determined using the bicincholinic
acid method with bovine serum albumin (BSA) as the standard.
Recombinant ChTx and ErgTx1 are obtained from Alomone (Jerusalem,
Israel). The potency of the recombinant ErgTx1 in suppressing HERG (see
Fig. 2) is very similar to that of native ErgTx1 previously determined under
the same conditions (Pardo-Lopez et al., 2002). Lyophilized toxin powders
were dissolved in 0.1% BSA in bath solution, aliquoted, and kept at 308C.
After thawing, each aliquot was kept on ice or at 48C and used in \2 days.

Cysteine (Cys) scanning mutagenesis
Wild-type (WT) HERG in a vector, pAlterMax, was used to produce Cys
mutants using the oligonucleotide-directed method and a commercial kit
(Altered SiteR Mammalian Mutagenesis System, Promega, Madison, WI).
Residues 571–613 (the S5-P linker), 631–638 (P-S6 linker), and 514–519
(S3-S4 linker) were substituted by Cys one at a time. In the following text,
the mutants are designated by the WT residue (one letter code), followed by
the position number and C for cysteine.

cRNA and oocyte preparations
cRNA was transcribed from cDNA using a commercial kit (T7 mMessage
mMachine, Ambion, Dallas, TX), resuspended in DEPC-treated water, and
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the concentration was quantiﬁed by densitometry (ChemiImager Model
4000, Alpha Innotech, San Leandro, CA). Oocytes were isolated from
Xenopus laevis and freed from follicular cell layers after mild collagenase
treatment. Each oocyte was microinjected with 40 nl of cRNA solution (total
cRNA 10–18 ng). After incubating the oocytes for 2–4 days at 168C in an
ND96 medium (composition given below) supplemented with horse serum
(4%) and antibiotics (penicillin 50 U/ml and streptomycin 50 U/ml),
channels were studied in electrophysiological experiments.

Electrophysiological experiments
Voltage clamp was done with the two-microelectrode method using an
oocyte clamp ampliﬁer (model 725B or 725C, Warner Instruments,
Hamden, CT). Voltage clamp protocol generation and data acquisition
were controlled by pClamp 5.5 via computer and a 12-bit D/A and A/D
converter (Axon Instruments, Union City, CA). Unless otherwise stated,
a typical experiment started with placing an oocyte in a tissue bath
containing 0.8 ml of low-[Cl] bath solution (to avoid interference from
endogenous Cl currents). The grounding electrodes were ﬁlled with 3 M KCl
(in contact with Ag/AgCl pellets) and connected to the bath solution with
salt bridges made of 1% agar in bath solution (to avoid perturbing ion
composition in the small volume of static bath solution). The oocyte was
impaled with two microelectrodes, and membrane currents were recorded.
The membrane voltage was held at 80 mV (Vh), and currents were
activated by a 1-s step to 120 mV applied once per 30 or 60 s. After control
currents (IC) were recorded, 5 ul of BeKm-1 stock solution (2 uM in 0.1%
BSA) was diluted with 0.2 ml of bath solution and added to the bath (ﬁnal
[BeKm-1] 10 nM, unless otherwise stated). Repetitive pipetting was used to
facilitate equilibration of toxin concentration in the bath. The remaining
current in the presence of BeKm-1 (ITX) was recorded when the degree of
current suppression reached a steady state. For the determination of
concentration-response relationship, the above procedure was modiﬁed. The
beginning BeKm-1 concentration in the bath solution was 1 nM (from 0.2
uM stock) and was increased cumulatively after the steady-state effect was
reached at each concentration (up to 100 nM). When higher concentrations
of toxin were needed (experiments shown in Figs. 2, 6, 7, and 10), BeKm-1
stock solutions were made at 20 and 200 uM. ErgTx1 and ChTx were
reconstituted and applied in the same manner. In some experiments (Fig. 3
A), oocytes were microinjected with salt solution immediately before recordings. This was done using the same device as for cRNA microinjection.

Solutions

FIGURE 2 BeKm-1 and ErgTx1 both suppress HERG with a high
potency, whereas ChTx has no effect at 100-fold higher concentration.
Shown are time courses of changes in HERG current amplitude before,
during, and after exposure to different concentrations of toxins (in nM,
denoted by different symbols as shown in panel C). Currents are elicited by
1-s depolarization pulses from Vh 80 mV to 120 mV once every 30 s. The
peak amplitudes of tail currents are measured and normalized by the control
current amplitude right before toxin application. Inset of each panel depicts
current traces recorded before (0) and during exposure to toxin at the
concentration (in nM) marked, with leak currents subtracted. Calibration
bars ¼ 1 uA.
Biophysical Journal 84(5) 3022–3036

The ND96 solution had the following composition (in mM): NaCl 96, KCl 2,
CaCl2 1.8, MgCl2 1, HEPES 5, and Na-pyruvate 2.5. The solution was
titrated to pH 7.5 with HCl. The standard low-[Cl] solution used during
voltage clamp experiments had a similar composition, except that NaCl and
KCl were replaced by NaOH and KOH, MgCl2 was replaced by MgSO4, and
the pH 7.5 was adjusted to 7.5 with methanesulfonic acid. The following
solutions were used in some experiments: a), 98 mM [K] solution, NaOH
was replaced by equimolar KOH and Na-pyruvate was omitted; b), low ionic
strength solution, NaOH was lowered to 20 mM using sucrose to maintain
the osmolarity; c), different pH solutions, pH of the standard solution was
titrated to 6.5 (with methanesulfonic acid) or 8.5 (with NaOH); and d), 50
mM TEA solution, the same as the standard low-[Cl] solution except that 50
mM Na was replaced by TEA.

Data analysis
Data analysis was performed using the following programs: Clampﬁt of
pClamp 6 or 8 (Axon Instruments), Excel (Microsoft), PeakFit, and
SigmaPlot (Jandel Scientiﬁc, San Rafael, CA). Pairwise statistical analysis
was done using t-test (SigmaStat, Jandel Scientiﬁc). Multiple-group
comparison was done using one-way ANOVA, followed by Dunn’s test.
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FIGURE 3 Effects of changing the intracellular or
extracellular ionic composition on BeKm-1 suppression
of HERG. (A) Increasing [K]i or [Na]i does not affect
BeKm-1’s potency but can inﬂuence the potency of
a standard outer mouth blocker, TEA. Oocytes are injected
with KCl or NaCl (see Methods, estimated increase in
cytoplasmic salt concentration 50 mM), and tested for
sensitivity to 10 nM BeKm-1 (top) or to 50 mM TEA
(bottom). Left and middle panels, original tail current traces
(elicited by the voltage clamp protocol shown in lower left
panel) recorded from KCl-injected or NaCl-injected
oocytes before (IC) and after addition of BeKm-1 (ITX) or
TEA (ITEA). Right panels, summary of ratios of tail
currents in the presence of BeKm-1 or TEA to control from
NaCl- or KCl-injected and uninjected oocytes (n ¼ 3 
14). (B) BeKm-1 potency is not affected by increasing [K]o
from 2 to 98 mM (top), but is reduced by outer mouth
occupancy by TEA (bottom). Left and middle panels,
original current traces (elicited by the protocol shown in
lower left panel) recorded in 2 and 98 mM [K]o, or in the
absence and presence of 50 mM TEA. Current traces
before and after BeKm-1 (10 nM) application are denoted
as in A. Right panels, summary of ratios of ITX to IC under
speciﬁed conditions. Dotted lines are reference for
measurement of peak tail current amplitudes. Calibration
bars ¼ 1 uA.

RESULTS
Fig. 2 compares the effects of BeKm-1, ErgTx1, and ChTx
on HERG. Both BeKm-1 and ErgTx1 can suppress the
HERG current in a concentration-dependent and reversible
manner (Fig. 2, A and B). For both, the degree of suppression reaches around 50% at 10 nM. However, neither toxin
can achieve a 100% suppression even at 1000 nM. Under
these conditions, the current traces display the rectiﬁcation
property characteristic of the HERG channel (more outward
current at 80 mV than at 120 mV), ruling out the possibility that these residual currents originate from oocyte
endogenous or ‘‘leak’’ conductance. The basis for the
residual HERG current seen in 1000 nM BeKm-1 will be
discussed further in a later section.
In contrast to the high potency of BeKm-1 and ErgTx1,
ChTx has no detectable effects on HERG at even 1000 nM
(Fig. 2 C). Therefore, although BeKm-1 shares the 3-D
scaffold with ChTx, its selectivity for HERG and the
blocking potency are similar to those of ErgTx1 (PardoLopez et al., 2002). However, a difference in the toxin
potency does not necessarily reﬂect signiﬁcant differences in
the structure of the toxin binding site. For example, ChTx

blocks the wild-type Shaker channel with a relatively weak
potency (dissociation constant, Kd, 120 nM). A single point
mutation, Shaker-F425G, can increase the potency of ChTx
by 2000-fold (Stocker and Miller, 1994). A mechanistic
study of toxin’s actions should provide more insights into
how the toxin binds to its receptor site and affect the channel
function. To study the mechanism of BeKm-1 action, we
characterize BeKm-1/HERG interaction in terms of its
sensitivity to changes in the extracellular or intracellular
ionic composition and to changes in membrane voltage. We
compare these characteristics with those of ErgTx1/HERG
and ChTx/Shaker interactions. The comparison with ChTx/
Shaker is particularly informative because much has been
learned about where ChTx binds to the Shaker channel and
how it blocks the current (Park and Miller, 1992; Goldstein
and Miller, 1993; Ranganathan et al., 1996; Gross and
MacKinnon, 1996; Goldstein et al., 1994). This information
can account for the well-deﬁned features of ChTx/Shaker
interaction: 1), The ChTx potency is reduced by an elevation
of the intracellular or extracellular K1 concentration ([K]i
and [K]o) (Ranganathan et al., 1996; Goldstein and Miller,
1993). This is because either intervention can increase K1
ion occupancy inside the pore, which destabilizes binding of
Biophysical Journal 84(5) 3022–3036
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the e-amino group of K27 near the selectivity ﬁlter (Park and
Miller, 1992). 2), The ChTx potency is reduced at stronger
membrane depolarization (Goldstein and Miller, 1993). This
occurs for two reasons. First, the increase in K1 efﬂux
through the pore at more depolarized voltages destabilizes
binding of K27’s e-amino group. Second, membrane
depolarization can also directly destabilize binding of this
amino group because the binding site is ;20% down the
transmembrane electrical ﬁeld (Goldstein and Miller, 1993).
And 3), The ChTx potency is enhanced by lowering the
extracellular ionic strength (Goldstein and Miller, 1993;
MacKinnon and Miller, 1989). This is because under these
conditions the ampliﬁed attractive forces between positive
charges on the toxin and negative charges on the outer
vestibule of the channel can help direct/orient the toxin
molecule toward its binding site (MacKinnon and Miller,
1989). Therefore, these aspects are where we begin to
characterize BeKm-1/HERG interaction and to deduce the
mechanism of toxin action.

Characteristics of BeKm-1/HERG interaction

Zhang et al.

other hand, although KCl injection can lead to a rise of [K]i
by 50 mM, the overall impact on K1 occupancy inside the
pore is less because the oocyte has a normal cytoplasmic [K]
around 120 mM. These data indicate that indeed we can
perturb the cytoplasmic ion concentration and inﬂuence ion
occupancy inside the HERG pore by intracellular injection of
high [salt] solution. Top panels of Fig. 3 A show that
compared to uninjected oocytes, neither NaCl nor KCl
injection has any detectable effects on BeKm-1 potency.
Therefore, unlike TEA, BeKm-1 binding to the HERG
channel is not sensitive to changes in K1 occupancy inside
the pore.
Effects of increasing [K]o on BeKm-1/HERG interaction

Top panels of Fig. 3 B show that elevating [K]o from 2 to 98
mM has no effect on the BeKm-1 potency in suppressing
HERG. This adds more support for the notion that BeKm-1
binding to the HERG channel is not affected by changing K1
ion occupancy around the selectivity ﬁlter. This situation is
different from that of ChTx/Shaker interaction (Ranganathan
et al., 1996; Goldstein and Miller, 1993), but similar to that
of ErgTx1/HERG interaction (Pardo-Lopez et al., 2002).

Effects of increasing [K]i on BeKm-1/HERG interaction

BeKm-1 does not have a K27-equivalent (Fig. 1). However, mutating BeKm-1’s K18, and to a lesser extent K23,
to alanine can substantially reduce the toxin’s potency
(Korolkova et al., 2002), leaving it possible that BeKm-1
may block the HERG pore by a mechanism similar to that of
ChTx using one of these lysine residues. In this case, we
expect to see a reduction of BeKm-1 potency when [K]i or
[K]o is elevated. Therefore, the ﬁrst question is: is BeKm-1’s
potency reduced by increasing [K]i? We use an approach
similar to that described by Wang et al. (1996): oocytes are
injected with concentrated NaCl or KCl solution (2.5 M, 10
nl per oocyte). The estimated increase in cytoplasmic salt
concentration is 50 mM. Injected oocytes are immediately
tested for BeKm-1 potency. To conﬁrm that our approach
can alter the cytoplasmic ion concentration and, more
importantly, ion occupancy inside the HERG pore, we test
the effects of NaCl or KCl injection on a standard outer
mouth blocker, tetraethylammonium (TEA) (bottom panels
of Fig. 3 A) (Smith et al., 1996). Compared with the TEA
potency in suppressing the HERG current in uninjected
oocytes, NaCl injection markedly accentuates the TEA
potency, whereas KCl injection has a small (statistically
insigniﬁcant) attenuating effect. The difference between
NaCl-injection and KCl-injection is profound (p \ 0.001).
These data can be explained by proposing that a higher
cytoplasmic Na1 concentration can compete with K1 ions
for entry into the HERG inner mouth. This can decrease K1
ion occupancy inside the pore. However, since Na1 ions do
not bind well to the selectivity ﬁlter or cannot reach as close
to the outer mouth as K1 ions, the stability of TEA binding
to the outer mouth is increased after NaCl injection. On the
Biophysical Journal 84(5) 3022–3036

Effects of an outer mouth blocker, TEA,
on BeKm-1/HERG interaction

Since BeKm-1 binding to the HERG channel is not sensitive
to changes in either [K]i or [K]o, our next question is: does
BeKm-1 bind near the HERG outer mouth? One way to
answer this question is to test whether the BeKm-1 potency
is affected by an outer mouth blocker. For example, TEA can
reduce the potency of both ChTx (in suppressing Shaker
current) and ErgTx1 (in suppressing HERG) (Goldstein and
Miller, 1993; Pardo-Lopez et al., 2002). The lower panels of
Fig. 3 B show that the BeKm-1 potency is also signiﬁcantly
reduced when tested in the presence of 50 mM TEA. The
sensitivity to TEA can be due to a steric effect (bound TEA
hinders BeKm-1 access to its binding site), and/or a charge
effect (the positive charge of bound TEA repels approaching
positively charged BeKm-1 molecules). The latter effect
occurs if positive charges on the BeKm-1 molecules can
inﬂuence toxin binding. To test whether this is the case, we
examine the effects of changing pHo on BeKm-1 potency.
Effects of changing pHo on BeKm-1/HERG interaction:
difference between BeKm-1 and ErgTx1

BeKm-1 has a isoelectric pH (pI) of 8.29 and carries \3
positive charges at neutral pHo (Fig. 1 A). Changing pHo
from 7.5 to 6.5 should increase the number of positive
charges on the toxin molecule, whereas changing pHo from
7.5 to 8.5 should abolish the positive charges or even make
the toxin negatively charged. Fig. 4 A (left panel) shows that
changing pHo from 7.5 to 6.5 enhances BeKm-1 potency,
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FIGURE 4 (A) Effects of changing pHo on BeKm-1
suppression wild-type HERG (WT, circles) and two histidine mutants (H578C, triangles, and H578K, inverted
triangles). Left, fractions of remaining current in the presence
of 10 nM BeKm-1 (ITX/IC) measured at 3 pHo levels. Voltage
clamp protocol and current measurement are as described for
Fig. 2. Right, comparison between BeKm-1 and ErgTx1 in
the proﬁle of pHo sensitivity of toxin suppression of WT
HERG and the two histidine mutants. The mean values of ITX/
IC measured at pHo 6.5 and 7.5 are normalized by the mean
ITX/IC value at pHo 8.5. BeKm-1 data are from the left panel
using the same symbols. ErgTx1 data (open gray symbols)
were obtained under the same conditions (Pardo-Lopez et al.,
2002). (B) BeKm-1/HERG or ErgTx1/HERG interaction is
insensitive to a decrease in extracellular ionic strength (S), in
sharp contrast to ChTx/Shaker interaction. Degrees of current
suppression by 10 nM BeKm-1 or ErgTx1 are measured in
solution of normal ionic strength (high S, ND96 with 96 mM
[Na]o, S ¼ 110 mM) and in solution of low ionic strength (low
S, [Na]o reduced to 20 mM with sucrose substitution, S ¼ 30
mM) at pHo 6.5, 7.5, and 8.5. The ITX/IC values are used to
estimate Kd values according to Eq. 1 (Fig. 7 legend, Amax ¼
0.9). The ratios of Kd in high S to that in low S are shown. To
avoid interference from effects of H578 protonation on
ErgTx1 potency, the effects of ErgTx1 are tested on H578C
((Pardo-Lopez et al., 2002), see right panel in A). The ChTx/
Sh data is from MacKinnon and Miller (1989), where S is
lowered from 110 to 50 mM.

whereas changing pHo from 7.5 to 8.5 reduces BeKm-1
potency. These observations support the notion that BeKm-1
binding to the HERG channel is facilitated by positive
charges on the toxin molecule.
This proﬁle of pHo sensitivity differs from that of ErgTx1
(Pardo-Lopez et al., 2002). The right panel of Fig. 4 A
compares the proﬁle of pHo sensitivity between BeKm-1 and
ErgTx1. To facilitate comparison, the fractions of remaining
current in the presence of 10 nM toxin (ITX/IC) at pHo 6.5 and
7.5 are normalized by that at pHo 8.5. The degree of BeKm-1
suppression of HERG shows an almost linear proﬁle in this
pHo range. On the other hand, although the potency of
ErgTx1 (pI 7.88, Fig. 1 B) is increased as pHo is acidiﬁed
from 8.5 to 7.5 (indicating that positive charges on ErgTx1
can facilitate binding to HERG), the potency is not further
increased at the pHo 7.5–6.5 transition. Previously we have
shown that this is due to a protonation of the histidine residue
at position 578 (H578): the added positive charge can
interfere with binding of positively charged ErgTx1 to the
channel. Therefore, after replacing this histidine with cysteine (H578C), acidifying pHo from 7.5 to 6.5 can cause
a further increase in ErgTx1 potency. On the other hand,
replacing the histidine with a ‘‘permanent’’ positive charge
(H578K) markedly reduces the ErgTx1 potency at pHo 6.5
and pHo 7.5 (when the toxin is positively charged), but not at
pHo 8.5 (when the toxin is neutral or even negatively
charged). On the other hand, neither H578C nor H578K
affects the proﬁle of pHo sensitivity of BeKm-1/HERG
interaction (although H578C modestly increases BeKm-1

potency, Fig. 4 A, left panel). Therefore, BeKm-1 differs
from ErgTx1 in that binding of BeKm-1 to the HERG
channel is shielded from the electrostatic repulsion of
a positive charge at position 578.
Effects of lowering the extracellular ionic strength
on toxin/channel interactions

We next test whether BeKm-1 binding to the HERG channel
can be enhanced by lowering the external ionic strength. We
run the test at pHo 6.5, 7.5, and 8.5, because the number and
sign of electrical charges on the toxin molecule, as well as
around its binding site on the channel, can impact on the
sensitivity of toxin-channel interaction to the surrounding ionic strength. Surprisingly, lowering the external ionic
strength (from 110 to 30 mM) does not affect BeKm-1
binding at any of the 3 pHo levels (Fig. 4 B). This is in sharp
contrast to the high sensitivity of ChTx/Shaker interaction to
a similar change in the external ionic strength (data from
(MacKinnon and Miller, 1989) shown in Fig. 4 B) We also
test how lowering the external ionic strength affects ErgTx1
suppression of H578C (to avoid the compounding effect of
H578 protonation on ErgTx1 binding) at the 3 pHo levels.
Similar to BeKm-1, the ErgTx1 potency is unaltered by this
intervention. Therefore, although positive charges on BeKm1 and ErgTx1 facilitate toxin binding to the HERG channel,
the electrostatic forces between toxin and the channel binding site are much weaker than those involved in ChTx/
Shaker interaction. This can be partly due to differences
Biophysical Journal 84(5) 3022–3036
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in the pI values, and thus the number of positive charges
carried by these toxins at comparable pHo (Fig. 1). Another
important factor is differences in the binding site: negative
charges on the outer vestibule of the Shaker channel are
critical for ChTx binding (MacKinnon and Miller, 1989),
whereas negative charges on the outer vestibule of the
HERG channel are not important for ErgTx1 binding (PardoLopez et al., 2002). This may also be the case for BeKm-1
(see below, Fig. 11 A).
Voltage-sensitivity of BeKm-1/HERG interaction

Similar to the voltage-sensitivity of ChTx/Shaker interaction
(Goldstein and Miller, 1993), membrane depolarization in
the range of 0–160 mV can clearly, although modestly,
reduce the BeKm-1 potency in suppressing HERG (Fig. 5).
This cannot be due to an increase in K1 efﬂux through the
pore, because the prominent C-type inactivation process
actually reduces K1 efﬂux in this voltage range (indicated by
the trace of normalized test pulse current, or It). The voltage
sensitivity cannot be due to binding of a positively charged
toxin moiety within the membrane electrical ﬁeld that experiences electrostatic repulsion by the membrane depolarization, based on the above data showing that changing K1

FIGURE 5 Voltage-sensitivity of BeKm-1 suppression of HERG and
a comparison with voltage-dependence of channel activation and inward
rectiﬁcation. The following voltage clamp protocol is used: from Vh 80
mV, 1-s depolarization pulses to Vt 70 to 160 mV in 10 mV increments
are applied once every 15 s. Peak tail current amplitudes (Itail) are measured
and the relationship between Vt and Itail is ﬁt with a single Boltzmann
function to estimate the maximum tail current amplitude (Imax), halfmaximum activation voltage (V0.5), and slope factor (k): Itail ¼ Imax/(1 1
exp((V0.5  Vt)/k)). Itail amplitudes are normalized by estimated Imax
(probability of opening, or Po), averaged and plotted against Vt. This is done
in pHo 6.5 and 8.5, and shown as gray open symbols. The peak tail current
amplitudes before (IC) and after (ITX) 10 nM BeKm-1 are measured and the
ITX/IC values are plotted against Vt (black open symbols). The average test
pulse current (It) of HERG at pHo 7.5 normalized by the maximal It at 0 mV
is shown as a dotted curve. Changing pHo from 6.5 to 8.5 has little or no
effects on the normalized It-Vt curve (Jiang et al., 1999).
Biophysical Journal 84(5) 3022–3036

Zhang et al.

ion occupancy inside the pore does not perturb BeKm-1
binding. Further support is provided by the observations that
although changing pHo from 6.5 to 8.5 (that should abolish
the positive charges on the toxin) reduces BeKm-1 potency,
it does not abolish this voltage sensitivity (Fig. 5). We
consider two possibilities. First, the voltage-sensitivity may
result from voltage-dependent interactions between BeKm-1
and the binding site on the HERG channel. In this scenario,
membrane depolarization decreases the BeKm-1 binding
afﬁnity, thus reducing the degree of current suppression.
Second, this voltage-sensitivity may reﬂect the effects of
BeKm-1 binding on HERG channel gating. In this scenario,
toxin-bound HERG channels can still conduct currents.
However, toxin binding alters channel gating by shifting the
voltage-dependence of activation in the positive direction, so
that current amplitude in the presence of BeKm-1 will
increase as the voltage becomes more positive (and more
toxin-bound channels become activated). The second possibility can explain the observation that BeKm-1 cannot
totally suppress the HERG current even at 1000 nM, ;100fold of the IC50 (Fig. 2 A).
Gating behavior of BeKm-1-bound HERG channels

To differentiate between these two possibilities, we analyze
the voltage-dependence of HERG activation in the presence
of 1000 nM BeKm-1 (when most channels are toxin-bound),
and compare it to that seen at a much lower toxin concentration (10 nM, when both toxin-free and toxin-bound
channels coexist). Fig. 6 A shows the HERG activation curve
under the control conditions and in the presence of 1000 nM
BeKm-1. With BeKm-1 on board, there is a prominent
positive shift of the activation curve along the voltage axis
(V0.5 shifted from 17.4 6 0.9 to 137.5 6 3.2 mV), and
a decrease in its slope (the k value increased from 9.0 6 0.3
to 24.8 6 1.7 mV). If this activation curve mainly reﬂects the
gating behavior of toxin-bound/conducting HERG channels,
then the activation curve in 10 nM BeKm-1 should have two
widely separated components: one representing toxin-free
channels and the other representing toxin-bound channels.
Fig. 6 B shows such an analysis from six oocytes exposed to
10 nM BeKm-1. Under the control conditions, the activation
curves follow a simple Boltzmann function. In the presence
of 10 nM BeKm-1, the activation curves in all six oocytes
require two Boltzmann components for a good ﬁt. The
negative component has parameter values indistinguishable
from those of control activation curve, whereas the positive
component has parameter values very similar to those of the
activation curve seen in 1000 nM BeKm-1 (listed in Fig. 6
legend).
A further test of these two hypotheses is to analyze the
HERG current kinetics in 1000 nM BeKm-1. Fig. 6 C shows
the apparent HERG activation rates at 140 and 160 mV
under the control conditions and in the presence of 1000 nM
BeKm-1. With BeKm-1 on board, the time constant (t) of
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FIGURE 6 Effects of BeKm-1 on the
activation gating properties of HERG. (A)
Effects of 1000 nM BeKm-1 on the voltagedependence of HERG activation. The voltage clamp protocol and current measurement/analysis are as described for Fig. 5.
Control: V0.5 ¼ 17.4 6 0.9 mV, k ¼ 9.0 6
0.3 mV; in 1000 nM BeKm-1: V0.5 ¼ 137.5
6 3.2 mV, k ¼ 24.861.7 mV. (B)
Activation curve in 10 nM BeKm-1. The
voltage clamp protocol and current measurement are the same as those shown in A.
The relationship between Vt and Itail requires
a double Boltzmann function for a good ﬁt:
Itail ¼ I1/(1 1 exp(V1  Vt)/k1)) 1 I2/(1 1
exp(V2  Vt)/k2)), where Ii, Vi, and ki
correspond to the Imax, V0.5, and k of the
ith Boltzmann component. The mean values
are: A1 ¼ 0.67 6 0.03, V1 ¼ 14.0 6 1.0
mV, k1 ¼ 8.0 6 0.3 mV, A2 ¼ 0.33 6 0.03,
V2 ¼ 131.0 6 3.2 mV, and k2 ¼ 18.1 6 0.9
mV. The dotted lines represent the two
separate Boltzmann components. (C) Effects
of 1000 nM BeKm-1 on time constant (t) of
activation determined by an envelope test.
Top, voltage clamp protocol: membrane
voltage is depolarized from Vh 80 mV to
Vt for various durations and the degree of
activation is tracked by the growth of peak
amplitude of outward tail current following
repolarization. Middle, superimposed tail current traces recorded before (IC) and during (ITX) BeKm-1 exposure with Vt to 140 mV. Envelope of peak tail
current amplitudes is ﬁt with a single exponential function to estimate tactivation. Bottom, summary of tactivation at 140 and 160 mV. (D) Effects of 1000 nM
BeKm-1 on t of deactivation. Inset, superimposed tail currents recorded at 80 mV (outward or upward) and at 120 mV (inward or downward) before (thin
traces) and during (thick traces) BeKm-1 exposure. The peak amplitudes of tail currents at the same Vr are matched to facilitate comparison. Data in panels A,
B, C (bottom), and D (main graph) are averaged from 3–7 measurements each. *in C and D, p \ 0.05.

activation is prolonged at both voltages (at 140 mV, from 68
6 23 to 171 6 9 ms). Fig. 6 D shows the apparent
deactivation rates in the voltage range of from 60 to 120
mV under the control conditions and in the presence of 1000
nM BeKm-1. At voltages positive to 90 mV, the t of
deactivation is shortened by BeKm-1. The most marked
change is at 60 mV: t deactivation is shortened from 171 6 10
to 104 6 10 ms. According to the ﬁrst hypothesis, the
slowing of HERG activation seen in BeKm-1 results
from voltage-dependent toxin unbinding from the channel,
whereas the acceleration of HERG deactivation reﬂects
a voltage-dependent rebinding reaction. If this were the case,
then these observed kinetic changes should be accounted for
by published data of BeKm-1 unbinding and binding rate
constants (Korolkova et al., 2002). The BeKm-1 unbinding
rate constant is 0.02 s1 (Korolkova et al., 2002). Therefore
the time constant of BeKm-1 unbinding is 50 s, more than
200-fold longer than the observed time constant of HERG
activation in 1000 nM BeKm-1. The BeKm-1 binding rate is
2.7 3 106 M1 s1 (Korolkova et al., 2002). At 1000 nM
toxin concentration, the binding rate is 2.7 s1. This
translates into a t of binding reaction of 367 ms, much
longer than the observed t of channel deactivation seen in
1000 nM BeKm-1. Therefore, alterations in the kinetics of

HERG activation and deactivation observed in the presence
of 1000 nM BeKm-1 are much too fast to be accounted for
by unbinding and rebinding reactions. Taken together, these
observations support the notion that BeKm-1-bound HERG
channels can conduct currents (although with reduced conductance), but have markedly altered gating kinetics.
The potency of ErgTx1 in suppressing HERG is also
reduced by membrane depolarization (Pardo-Lopez et al.,
2002). This voltage-sensitivity may be due to the same
mechanism as is suggested by data shown in Fig. 2 B: in the
presence of 1000 nM ErgTx1 the residual HERG current has
markedly slowed activation and accelerated deactivation
kinetics.
Apparent concentration-response relationship
of BeKm-1 suppression of HERG
We examine the effects of 1–1000 nM BeKm-1 on the
HERG current amplitude, using the same voltage clamp protocol and data analysis as those described for Fig. 2. The
relationship between toxin concentration ([TX]) and fraction
of remaining current (ITX/IC) are summarized in Fig. 7 (open
squares, data obtained in 2 mM [K]o, n ¼ 3–14). Since ITX/
IC results from a combination of toxin-free channels and
Biophysical Journal 84(5) 3022–3036
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FIGURE 7 Concentration-response relationships of BeKm-1 suppression
of HERG measured in 2 and 98 mM [K]o. The voltage clamp protocol and
current measurement are the same as those described for Fig. 2. Relationship
between fraction of remaining current (ITX/IC) and toxin concentration
([TX]) is ﬁt with the following equation: ITX/IC ¼ Amax/(1 1 [TX]/Kd) 1
(1  Amax) (Eq. 1), where Amax is the fraction of toxin-sensitive current
component and Kd is the dissociation constant. Each data point is
summarized from 3 to 17 measurements. For 2 mM [K]o, Amax ¼ 0.88 6
0.01, and Kd ¼ 4.4 6 0.2 nM. For 98 mM [K]o, Amax ¼ 0.81 6 0.03, and
Kd ¼ 3.2 6 0.6 nM (for both parameters, p[0.05). The superimposed curves
are calculated from Eq. 1, with the mean parameter values listed above.

toxin-bound channels with altered conductance and gating
kinetics, this concentration-response relationship does not
reﬂect the molecular binding and unbinding events. Nevertheless, it serves as a quantitative description of toxin potency
under the deﬁned conditions. This apparent concentrationresponse relationship can be well described by the following
equation:
ITX =IC ¼ Amax =ð1 1 ½TX=Kd Þ 1 ð1  Amax Þ;

FIGURE 8 BeKm-1 application reduces the suppressing effects of
subsequent ErgTx1 on HERG and vice versa. (A) Time course of changes
in current amplitude from a representative experiment. The voltage clamp
protocol and current measurement are the same as those described for Fig. 2.
[K]o is 2 mM and [TX] for both BeKm-1 and ErgTx1 is 10 nM. The
durations of toxin exposures are marked by horizontal bars on top. Toxin
effects are washed out between 12 and 20 min. (B) Summary of BeKm-1
effects without or with preapplication of ErgTx1 (left) and ErgTx1 effects
without or with preapplication of BeKm-1 (right). Data are pooled from six
experiments. Three are done in the order shown in A, and the other three are
done in the reverse order. The percentages of current suppression are
calculated as illustrated by the arrows in A.

(1)

where Amax is the fraction of BeKm-1 sensitive current
component (0.88 6 0.01), and Kd is the apparent dissociation
constant of BeKm-1 (4.4 6 0.2 nM). Fig. 7 also shows that
the potency of BeKm-1 is not affected by elevating [K]o
from 2 to 98 mM, consistent with data presented in Fig. 3 B.
The concentration-response relationship of BeKm-1 is
very similar to that of ErgTx1 (Pardo-Lopez et al., 2002).
Both can be described by the same equation, with comparable Kd values and similar maximal effects (;90%
suppression of the HERG current).

Finding the BeKm-1 binding site on the
HERG channel

causes a 65% reduction in the HERG current. Subsequent
application of BeKm-1 (10 nM) in the continuous presence
of ErgTx1 causes only a 32% decrease in the current amplitude, measured relative to the current at the steady-state
effect of ErgTx1. After washing out both toxins, the current
amplitude recovers to near the control level. Toxins of the
same concentration are applied in the reverse order. In this
case, BeKm-1 alone causes a 60% decrease in the current
amplitude whereas subsequent application of ErgTx1 causes
only a 25% decrease. Fig. 8 B summarizes results from six
experiments—three are done in the order shown in Fig. 8 A,
and three are done in the reverse order. The effect of BeKm-1
is attenuated by a prior application of ErgTx1, and vice
versa. This is consistent with the notion that the two toxins’
binding sites on the channel may be close to each other.

Is BeKm-1 binding site close to that of ErgTx1?

The above data indicate that BeKm-1 and ErgTx1 share
similar features in their interaction with the HERG channel.
Do they bind to the same or similar domains on the HERG
channel? Fig. 8 A depicts the time course of a typical
competition experiment. Application of ErgTx1 (10 nM)
Biophysical Journal 84(5) 3022–3036

Using the cysteine scanning mutagenesis approach to
explore the BeKm-1 binding site

We examine the effects of cysteine mutations in the outer
vestibule of HERG on BeKm-1 potency. The regions examined include positions 514–519 (S3-S4 linker), 571–613
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(S5-P linker), and 631–638 (P-S6 linker) (Fig. 9 A). Recordings are made in 98 mM [K]o to enhance current amplitude
of some poorly expressed mutants. This is justiﬁed because BeKm-1 binding to the HERG channel is insensitive
to such a change in [K]o (Fig. 3 B). Currents are elicited by
1-s depolarization pulses to 120 mV, and peak amplitudes
of tail currents at 80 mV are used to monitor the degrees of
suppression by the toxin. Fig. 9 B depicts current traces of
WT HERG and selected cysteine mutants in the absence
and presence of 10 nM BeKm-1. The WT and N588C
currents are markedly reduced by BeKm-1, whereas those
of Q592C and P632C are not affected at all. For those cysteine mutants that show markedly reduced BeKm-1 sensitivity (W585C, G590C, Q592C, I593C, S631C, and P632C),
toxin concentration is increased up to 200 nM when a discernible current suppression can be seen. The apparent Kd
values are estimated by measurements based on one toxin
concentration, using Eq. 1 with an assumed Amax value of 0.9
(Fig. 7). The Kd values are used to calculate mutationinduced changes in toxin binding free energy (DDG). Fig. 10
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summarizes all the data: DDG values are plotted against
channel residues along the abscissa with selected position
numbers labeled. The histogram bars are color coded by their
DDG values. Four cysteine mutations perturb toxin binding
by [3 kcal/mol (black histogram bars, W585C, G590C, and
Q592C in the 583–597 segment, and P632C in the P-S6
linker), two mutations perturb the binding energy in the 2–3
kcal/mol range (gray histogram bars, I593C in the 583–597
segment and S631C at the pore entrance), and six mutations perturb the binding energy in the 1–2 kcal/mol range
(hatched histogram bars, I571C outside the S5, L589C,
D591C, and P596C in the 583–597 segment, T613C at the
pore entrance, and P605C). These data suggest the possibility that the BeKm-1 binding site on the HERG channel
may be formed with contributions from the 583–597 segment
of the S5-P linker and residues near the pore entrance
(T613C and S631C).
However, cysteine substitution at a number of locations
in the HERG’s outer vestibule region can alter channel
function. Speciﬁcally, these mutations can cause a disruption

FIGURE 9 (A) Partial amino acid sequence of HERG in the outer vestibule region (from the end of S5 to the beginning of S6) and in the S3-S4 linker.
Channel domains are marked on top. Position numbers of residues substituted by cysteine are noted: 514–519 of S3-S4 linker, 571–613 of S5-P linker (with
583–597 segment shown as an insert), and 631–638 of P-S6 linker. (B) Original current traces of WT and three selected cysteine-substituted mutants recorded
before (IC) and after (ITX) application of 10 nM BeKm-1. Recordings are done in 98 mM [K]o using the voltage clamp protocol shown in inset of WT panel. (C)
Current-voltage relationships of WT and the same three mutants. The voltage clamp protocol is diagrammed in the inset of WT panel: a 0.2 s conditioning pulse
to 160 mV is used to activate (and inactivate) channels, followed by repolarization to Vr 1 30 to 120 mV in 10 mV increments. Recordings are done in 2 mM
[K]o. The plateau or peak amplitudes of tail currents are measured, normalized by the maximal outward tail currents in the same oocyte (at 60 mV for WT and
Q592C, and at 130 mV for N588C and P632C), averaged and plotted against Vr. The gray shades highlight the region of the I/V curves showing a negative
slope in WT and Q592C (due to C-type inactivation) but a positive slope in N588C and P632C (due to a disruption of C-type inactivation). Note also the
correlated difference in the reversal potential: ;100 mV for WT and Q592, and ;20 mV for N588C and P632C. Calibration bars ¼ 1 uA.
Biophysical Journal 84(5) 3022–3036
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FIGURE 10 Effects of Cys substitutions in the S3-S4, S5-P, and P-S6
linkers of HERG on sensitivity to
BeKm-1. The recording conditions,
voltage clamp protocol, and current
measurement are the same as those
described for Fig. 9 B. One toxin
concentration (10 nM) is used for
WT HERG and all Cys mutants, except
W585C, G590C, Q592C, I593C,
S631C, and P632C. For these mutants
that have markedly reduced BeKm-1
sensitivity, cumulative toxin concentrations of 50, 100, and 200 nM are used.
The fraction of remaining current (ITX/
IC) is used to estimate the Kd value
according to Eq. 1 with Amax ¼ 0.9
based on Fig. 7. The Kd value is used to calculate the mutation-induced alteration in binding free energy (DDG), according to: DDG ¼ RTln(Kdmut/KdWT),
where Kdmut and KdWT are the calculated Kd values for mutant and WT channels, and RT ¼ 0.6 kcal/mol. The KdWT value averaged from these experiments in
which one toxin concentration (10 nM) is used is 6.0 6 0.4 nM (n ¼ 14). For all the Kdmut values, n ¼ 3  6 each, but n ¼ 1 for: 1), the six Cys mutants listed
above where high BeKm-1 concentrations are used (although the lack of sensitivity to 10 nM BeKm-1 is conﬁrmed in three or four measurements each), and 2),
514–519 mutants. Data are color coded based on the magnitudes of perturbation in binding free energy: white bars (DDG \ 1 kcal/mol), hatched bars (DDG
between 1 and 2 kcal/mol), gray bars (DDG between 2 and 3 kcal/mol), and black bars (DDG [ 3 kcal/mol). Data are plotted against WT residues along the
abscissa, with selected position numbers marked. The 583–597 segment is boxed. Channel domains S3-S4, S5-P, and P-S6 linkers are also marked. Oocytes
expressing Cys mutants have been pretreated by DTT (5 mM, up to 4 h) and thoroughly rinsed in bath solution before recording. No data for the following
mutants that have little or no expression: N573C, K595C, N633C, E637C, and K638C (marked by *).

of C-type inactivation, a decrease in the K1 selectivity, and
a negative shift in the voltage-dependence of activation (Liu
et al., 2002). Two examples are illustrated in Fig. 9 C. The
I-V curves of WT HERG and Q592C (a mutant with WTlike behavior) show a prominent negative slope in the
voltage range from 130 to 60 mV. This is due to the strong
C-type inactivation process that shuts down currents at positive voltages. Furthermore the reversal potential (Erev) is
very close to the predicted K1 equilibrium potential (EK), indicating a strong K1 selectivity. On the other hand, the I-V
curves of N588C and P632C show a positive slope in the
same voltage range (C-type inactivation disrupted) and an
Erev around 10 mV (K1 selectivity reduced). Therefore the
interpretation of data presented in Fig. 10 can be compounded by the possibility that cysteine mutations may alter
the BeKm-1 binding afﬁnity by inducing global conformational changes in the outer vestibule that propagate to the
toxin binding site. An argument against this possibility is
shown in Fig. 9: cysteine substitution disrupts C-type
inactivation and K1 selectivity in N588C, but the BeKm-1
sensitivity is unaltered. On the other hand, Q592C has a
WT-like behavior in terms of C-type inactivation and
K1 selectivity, but its BeKm-1 sensitivity is dramatically
reduced. Such a dissociation between mutation-induced
disruption of channel function and changes in BeKm-1
sensitivity is also clear from the summary data in Fig. 10.
In addition to N588C, the following cysteine substituted
channels have mutant (altered) channel behavior but the
same BeKm-1 sensitivity as WT HERG: G572C, L586C,
and T634C. Beside Q592C, the following channels have
WT-like behavior but drastically reduced BeKm-1 sensitivity: P596C, T613C, and S631C.
Biophysical Journal 84(5) 3022–3036

Since BeKm-1’s actions on the HERG channel have the
characteristics of a ‘‘gating modiﬁer’’ (depolarizing shift in
the voltage-dependence of channel activation) (Swartz and
MacKinnon, 1997a), we also examine the effects of cysteine
substitution in the S3-S4 linker, a ‘‘hot spot’’ for binding of
gating modiﬁer toxins (Swartz and MacKinnon, 1997b; LiSmerin and Swartz, 1998; Cestele et al., 1998). Cysteine
substitutions in the S3-S4 linker do not affect BeKm-1
binding (Fig. 10).
DISCUSSION
Our ﬁndings can be summarized as the following: 1), BeKm1 binds to the HERG channel near the pore entrance (because
cysteine substitutions around the pore entrance or TEA
binding to the pore reduce the toxin potency), without having
a positively charged toxin moiety protruding into the pore
(because toxin potency is insensitive to elevation in [K]i or
[K]o). 2), Positive charges on the toxin molecule facilitate
binding to the channel (because acidifying pHo from 8.5 to
6.5 increases positive charges on the toxin and enhances the
toxin potency), but electrostatic forces are not a major factor
in toxin/channel interaction (because the toxin potency is
insensitive to lowering the external ionic strength, or to
a neutralization of negative charges in the outer vestibule
region: E575, D580, and D609). 3), BeKm-1-bound HERG
channel can still conduct currents with a lowered conductance and drastically altered gating kinetics: more than 150
mV shift in the midpoint of activation curve, slowed activation, and accelerated deactivation. Therefore, BeKm-1
behaves both as a pore blocker and as a gating modiﬁer. 4),
Residues around the extracellular pore entrance and in the
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583–597 segment of the S5-P linker are involved in forming
the BeKm-1 binding site. And 5), S3-S4 linker is not
involved in BeKm-1 binding.
Unique outer vestibule structure
of the HERG channel
We have proposed that the outer vestibule of the HERG
channel is unique among K channels. This is indicated by
a comparison of amino acid sequences between HERG and
other K channels: the S5-P linker that lines the outer
vestibule of K channels is much longer in HERG (43 aa) than
in other K channels (12–23 aa) (e.g., Fig. 11 A). This
uniqueness is also indicated by the functional aspects of the
HERG channel. The C-type inactivation process, which
reﬂects conformational changes around a channel’s outer
mouth, is much faster and voltage-sensitive in HERG than in
other Kv channels (Spector et al., 1996). The uniqueness is
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further supported by the cysteine mutagenesis data (Liu
et al., 2002): mutations introduced into the middle of the
S5-P linker, not contiguous with the channel pore in onedimensional sequence, can have profound effects on the
HERG’s pore properties (C-type inactivation and K:Na
selectivity) and the voltage-dependence of activation. We
have proposed that positions 583–597 in the HERG’s S5-P
linker form an amphipathic a-helix, with its amino end near
the channel pore and carboxyl end close to the voltagesensing domain. In this model, the 583–597 helix serves as
a bridge of communication between the pore and the voltagesensing domain. Our ﬁndings here are consistent with such
a topology: the 583–597 segment and the pore entrance are
close to each other in 3-D space so that residues in these two
regions together form the BeKm-1 binding site.
Although BeKm-1 shares the 3-D scaffold with other
a-KTx members, its mechanism of action and interaction
surface differ from those of ChTx and AgTx2 (Fig. 11 B).

FIGURE 11 (A) Alignment of partial amino acid sequences of MthK, KcsA, Shaker, and HERG. S5 (equivalent to M1 in MthK and KcsA), P-loop, and S6
(M2) are underlined. S5-P linker (equivalent to ‘‘turret’’ in KcsA) and P-S6 linkers are delineated on top. Gaps (denoted by periods) are introduced to improve
the alignment. For HERG, the segment from positions 583 to 597 is shown as an insert. Gray shades highlight the Shaker residues important for ChTx or
AgTx2 binding. HERG residues important for BeKm-1 and ErgTx1 binding (DDG [ 1 kcal/mol, Fig. 10 and Pardo-Lopez et al. (2002)) are highlighted by
solid circles and open squares, respectively. H578 is circled. (B) NMR structures of BeKm-1 and AgTx2, color coded by the effects of mutations on binding
afﬁnity for HERG and Shaker, respectively. (C) Cartoon highlighting the differences and similarities in toxin-channel interactions: AgTx2 binding to the
Shaker channel and BeKm-1 or ErgTx1 binding to the HERG channel. AgTx2 and BeKm-1 are shown as having the same 3-D scaffold (denoted by the same 2D contour), but differ in: a), interaction surface used to bind to the outer vestibule of their target K channels, b), amount of net positive charges on the toxin
surface, c), electrostatic forces involved in toxin-channel interaction, and d), ability to experience repulsion by K1 ions inside the pore. The Shaker and HERG
channels are each depicted as a solid structure with a central channel pore, but differ in: a), the outer mouth dimension (wider in Shaker than in HERG), b),
inner mouth dimension (wider in HERG than in Shaker), and c), an a-helix formed by the 583–597 segment of S5-P linker in the HERG outer vestibule
(depicted as a semicircle). ErgTx1 is depicted as having a very different 3-D structure (denoted by a 2-D contour different from those of AgTx2 or BeKm-1),
but using an interaction surface similar to that of BeKm-1. BeKm-1 and ErgTx1 differ in their response to protonation of a histidine residue (H578) in the 583–
597 a-helix of the HERG channel (H attached to the semicircle).
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These points are symbolized in Fig. 11 C. In the cartoon, the
HERG outer mouth is narrower than that of the Shaker
channel. There are two reasons for this assumption. First,
several hydrogen bonds that are important in maintaining the
Shaker outer mouth in the open conﬁguration (Larsson and
Elinder, 2000) are missing in the HERG channel (Doyle
et al., 1998). This will make the HERG outer mouth more
ﬂexible and easier to collapse. Second, the ﬂexibility of
HERG’s outer mouth may allow part of the S5-P linker, e.g.,
the 583–597 a-helix, to line the pore entrance. This will
narrow the outer mouth diameter. The cartoon in Fig. 11 C
also shows a wider inner cavity in the HERG channel than
that of the Shaker channel. This is in keeping with the
observations that many chemicals can enter the inner mouth
of the HERG channel and become trapped inside the pore by
the closure of the cytoplasmic activation gate (Mitcheson
et al., 2000).
BeKm-1 and ErgTx1 are useful tools to
probe the structure of the outer vestibule of
the HERG channel
BeKm-1 and ErgTx1 differ in their disulﬁde bridging pattern
and do not share any signiﬁcant homology in the amino acid
sequence (Fig. 1). In terms of interaction with the HERG
channel, BeKm-1 and ErgTx1 share the following features:
1), concentration-response relationship (apparent 1:1 binding stoichiometry with a maximum of ;90% suppression of
current amplitude); 2), sensitivity to pHo (acidifying pHo
enhances toxin-HERG interaction); 3), sensitivity to TEA
(50 mM TEA signiﬁcantly attenuates toxin potency); 4),
insensitivity to elevating [K]o (from 2 to 98 mM); 5),
insensitivity to lowering the external ionic strength (from
110 to 30 mM); and 6), voltage-sensitivity (depolarization
modestly reduces the apparent potency of both toxins). The
voltage-sensitivity of these two toxins may arise from the
same mechanism: toxin-bound channels conduct currents but
with altered gating kinetics. Furthermore, the two toxins
attenuate each other’s potency in suppressing the HERG
current, suggesting that their binding sites on the HERG
channel are close to each other or overlap.
We propose that BeKm-1 and ErgTx1 suppress the HERG
current by the same mechanism, and share similarities in
their interaction surfaces (Fig. 11 C). However, there are also
important differences between BeKm-1 and ErgTx1 in terms
of their contact points with the channel and the binding site
environment. First, the impact of protonating histidine at
position 578 at acidic pHo on toxin binding differs between
BeKm-1 (no impact) and ErgTx1 (reduced binding). Second, cysteine substitutions at the following positions affect
BeKm-1 binding, but not ErgTx1 binding: I571, L589,
D591, P596, P605, and S631 (Fig. 11 A). In particular, the
difference in the impact of S631C (a mutation right at the
edge of the pore entrance) suggests that BeKm-1 may bind
deeper into the pore than ErgTx1, and thus senses the effects
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of mutating the 631 side chain. Mutant cycle analysis with
BeKm-1 and ErgTx1, the latter’s NMR structure, is available
(Torres et al., 2003) and provides important insights into the
unique structure of the outer vestibule of the HERG channel.
BeKm-1 as a gating modiﬁer?
Although BeKm-1 binding has profound effects on the
activation gating process of the HERG channel, its binding
site and mechanism of action differ from those of hanatoxin,
a well studied K channel gating modiﬁer toxin (Swartz and
MacKinnon, 1997b; Li-Smerin and Swartz, 2000). Hanatoxin
binds to the S3-S4 linker of DRK1 with a 4:1 stoichiometry, and mutations in the pore and outer vestibule region
have no effects on toxin binding. On the other hand, cysteine
substitutions in HERG’s outer vestibule region, but not in
the S3-S4 linker, have marked effects on BeKm-1 binding,
and the apparent concentration-response relationship can
be described by a 1:1 stoichiometry. Therefore, BeKm-1
does not act like a ‘‘conventional’’ gating modiﬁer (LiSmerin and Swartz, 1998). We propose that the effects of
BeKm-1 on HERG gating are due to the unique role of S5-P
linker in this channel: S5-P linker is critically involved in the
gating transitions that lead to the opening of the HERG pore
(Liu et al., 2002). Therefore, a bound BeKm-1 molecule that
makes contacts with this linker can have marked impact on
the voltage-dependence and kinetics of activation and
deactivation.
Technical consideration
In this study, we test the BeKm-1 potency on HERG
channels expressed in Xenopus oocytes using a static bath
volume of 1 ml. There are two concerns in this experimental
design. First, the oocyte cell membrane has invaginations
that may hinder the access of peptide toxin to a subpopulation
of channels deep in the invaginations. Can this account for
the BeKm-1-insensitive component of HERG current as
shown in Fig. 2 A? If indeed there were a subpopulation of
HERG channels inaccessible to the peptide toxin, a corollary
is that the markedly altered gating behavior seen in the
presence of 1000 nM BeKm-1 should largely reﬂect the
gating properties of these inaccessible HERG channels
(Fig. 6 A). Under the control conditions, no such current
component is ever seen. Therefore, we conclude that the
current component seen in the presence of 1000 nM BeKm-1
mainly represents the residual current through toxin-bound
channels. Second, can there be a problem of toxin depletion
in the static bath? The problem of peptide sticking to the
plastic tissue well can be reduced by including 0.1% bovine
serum albumin in the solution (see Materials and Methods).
However, at low concentrations the toxin may still be
partially depleted due to nonspeciﬁc binding to the oocyte
cell surface. Although we cannot be certain as to the degree
of toxin depletion in our experiments, it is important to point
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out that the BeKm-1 potency estimated in our experiments
(apparent Kd of 4.4 nM, with a maximal effect of 88%
reduction) is not very different from that estimated by testing
the toxin potency on HERG expressed in HEK 293 cells
using a ﬂowing bath (Kd 3.3 nM, with ;90% reduction at
100 nM) (Korolkova et al., 2001). It is also important to
point out that using a static bath does not allow us to measure
the rate constants of toxin binding and unbinding, which are
essential in gaining mechanistic information about toxinchannel interactions.
The authors thank Dr. L. D. Possani for providing the native ErgTx1 for
part of the experiments shown in Fig. 4 B, and Dr. Eduard V. Bocharov for
helping preparing Fig. 11 B.
This study is supported by grants HL 46451 and HL 67840 from the
National Heart, Lung and Blood Institute, National Institutes of Health, and
a grant-in-aid from the American Heart Association Mid-Atlantic Afﬁliate,
to G.-N.T., and grant 01-04-48338 from the Russian Foundation of Basic
Research to E.V.G.

REFERENCES
Capener, C., I. Shrivastava, K. Ranatunga, L. Forrest, G. Smith, and M.
Sansom. 2000. Homology modeling and molecular dynamics simulation
studies of an inward rectiﬁer potassium channel. Biophys. J. 78:2929–
2942.
Castle, N. 1999. Recent advances in the biology of small conductance
calcium-activated potassium channels. In Perspectives in Drug Discovery
and Design 15/16. H. Darbon and J. Sabatier, editors. Kluwer, The
Netherlands. 131–154.
Cestele, S., Y. Qu, J. Rogers, H. Rochat, T. Scheuer, and W. Catterall.
1998. Voltage sensor-trapping: enhanced activation of sodium channels
by b-scorpion toxin bound to the S3-S4 loop in domain II. Neuron.
21:919–931.
Chen, J., G. Seebohm, and M. Sanguinetti. 2002. Position of aromatic
residues in the S6 domain, not inactivation, dictates cispride sensitivity of
HERG and eag potassium channels. Proc. Natl. Acad. Sci. USA.
99:12461–12466.
Doyle, D., J. Cabral, R. Pfuetzner, A. Kuo, J. Gulbis, S. Cohen, B. Chait,
and R. MacKinnon. 1998. The structure of the potassium channel:
molecular basis of K1 conduction and selectivity. Science. 280:69–77.
Faravelli, L., A. Arcangeli, M. Olivotto, and E. Wanke. 1996. A HERG-like
K1 channel in rat F-11 DRG cell line: pharmacological identiﬁcation and
biophysical characterization. J. Physiol. 496:13–23.
Goldstein, S., and C. Miller. 1993. Mechanism of charybdotoxin block of
a voltage-gated K1 channel. Biophys. J. 65:1613–1619.
Goldstein, S., D. Pheasant, and C. Miller. 1994. The charybdotoxin receptor
of a Shaker K1 channel: peptide and channel residues mediating
molecular recognition. Neuron. 12:1377–1388.
Gross, A., and R. MacKinnon. 1996. Agitoxin footprinting the Shaker
potassium channel pore. Neuron. 16:399–406.
Gurrola, G., B. Rosati, M. Rocchetti, G. Pimienta, A. Zaza, A. Arcangeli,
M. Olivotto, L. Possani, and E. Wanke. 1999. A toxin to nervous,
cardiac, and endocrine ERG K1 channels isolated from Centruroides
noxius scorpion venom. FASEB J. 13:953–962.
Hidalgo, P., and R. MacKinnon. 1995. Revealing the architecture of a K1
channel pore through mutant cycles with a peptide inhibitor. Science.
268:307–310.
Jiang, M., W. Dun, and G.-N. Tseng. 1999. Mechanism for the effects of
extracellular acidiﬁcation on HERG channel function. Am. J. Physiol.
277:H1283–H1292.

3035
Jiang, Y., A. Lee, J. Chen, M. Cadene, B. Chait, and R. MacKinnon. 2002.
The open pore conformation of potassium channels. Nature. 417:523–
526.
Korolkova, Y., E. Bocharov, K. Angelo, I. Maslennikov, O. Grinenko, A.
Lipkin, E. Nosireva, K. Pluzhnikov, S.-P. Olesen, A. Arseniev, and E.
Grishin. 2002. New binding site on the old molecular scaffold provides
selectivity of HERG-speciﬁc scorpion toxin BeKm-1. J. Biol. Chem.
277:43104–43109.
Korolkova, Y., S. Kozlov, A. Lipkin, K. Pluzhnikov, J. Hadley, A.
Filippov, D. Brown, K. Angelo, D. Strobaek, T. Jespersen, S.-P. Olesen,
B. Jensen, and E. Grishin. 2001. An ERG channel inhibitor from the
scorpion Buthus eupeus. J. Biol. Chem. 276:9868–9876.
Larsson, H., and F. Elinder. 2000. A conserved glutamate is important for
slow inactivation in K1 channels. Neuron. 27:573–583.
Lecchi, M., E. Redaelli, B. Rosati, G. Gurrola, T. Florio, O. Crociani, G.
Curia, R. Cassulini, A. Masi, A. Acrangeli, M. Olivotto, G. Schettini, L.
Possani, and E. Wanke. 2002. Isolation of a long-lasting eag-related
gene-type K1 current in MMQ lactotrophs and its accommodating role
during slow ﬁring and prolactin release. J. Neurosci. 22:3414–3425.
Li-Smerin, Y., and K. Swartz. 1998. Gating modiﬁer toxins reveal
a conserved structural motif in voltage-gated Ca21 and K1 channels.
Proc. Natl. Acad. Sci. USA. 95:8585–8589.
Li-Smerin, Y., and K. Swartz. 2000. Localization and molecular
determinants of the hanatoxin receptors on the voltage-sensing domains
of a K1 channel. J. Gen. Physiol. 115:673–684.
Lipkind, G., and H. Fozzard. 1997. A model of scorpion toxin binding to
voltage-gated K1 channels. J. Mol. Biol. 158:187–196.
Liu, J., M. Zhang, M. Jiang, and G.-N. Tseng. 2002. Structural and
functional role of the extracellular S5-P linker in the HERG potassium
channel. J. Gen. Physiol. 120:723–737.
MacKinnon, R., and C. Miller. 1989. Mutant potassium channels with
altered binding of charybdotoxin, a pore-blocking peptide inhibitor.
Science. 245:1382–1385.
Miller, C. 1995. The charybdotoxin family of K1 channel-blocking
peptides. Neuron. 15:5–10.
Mitcheson, J., J. Chen, and M. Sanguinetti. 2000. Trapping of
a methanesulfonanilide by closure of the HERG potassium channel
activation gate. J. Gen. Physiol. 115:229–239.
Nastainzyk, W., H. Meves, and D. Watt. 2002. A short-chain peptide toxin
isolated from Centruroides sculpturantus scorpion venom inhibits ethera-go-go-related gene K1 channels. Toxicon. 40:1053–1058.
Numaguchi, H., F. Mullins, J. Johnson, D. Johns, S. Po, I. Yang, G.
Tomaselli, and J. Balser. 2000. Probing the interaction between
inactivation gating and d-sotalol block of HERG. Circ. Res.87:1012–
1018.
Pardo-Lopez, L., M. Zhang, J. Liu, M. Jiang, L. Possani, and G.-N. Tseng.
2002. Mapping the binding site of a HERG-speciﬁc peptide toxin
(ErgTx) to the channel’s outer vestibule. J. Biol. Chem. 277:16403–
16411.
Park, C.-S., and C. Miller. 1992. Interaction of charybdotoxin with
permeant ions inside the pore of a K1 channel. Neuron. 9:307–313.
Ranganathan, R., J. Lewis, and R. MacKinnon. 1996. Spatial localization of
the K1 channel selectivity ﬁlter by mutant cycle-based structure analysis.
Neuron. 16:131–139.
Rauer, H., M. Lanigan, M. Pennington, J. Aiyar, S. Ghanshani, M. Cahalan,
R. Norton, and K. Chandy. 2000. Structure-guided transformation of
charybdotoxin yields an analog that selectively targets Ca21-activated
over voltage-gated K1 channels. J. Biol. Chem. 275:1201–1208.
Roche, O., G. Trube, J. Zuegge, P. Pﬂimlin, A. Alanine, and G. Schneider.
2002. A virtual screening method for prediction of the HERG potassium
channel liability of compound libraries. Chem Bio Chem. 3:455–459.
Roden, D., and J. Balser. 1999. A plethora of mechanisms in the HERGrelated long QT syndrome. Genetics meets electrophysiology. Cardiov
Res. 44:242–246.
Rosati, B., P. Marchetti, O. Crociani, M. Lecchi, R. Lupi, A. Arcangeli, M.
Olivotto, and E. Wanke. 2000. Glucose- and arginine-induced insulin
Biophysical Journal 84(5) 3022–3036

3036
secretion by human pancreatic b-cells: the role of HERG K1 channels in
ﬁring and release. FASEB J. 14:2601–2610.
Sanguinetti, M., C. Jiang, M. Curran, and M. Keating. 1995. A mechanistic
link between an inherited and an acquired cardiac arrhythmia: HERG
encodes the IKr potassium channel. Cell. 81:299–307.

Zhang et al.
Torres, A. M., P. Bansal, P. F. Alewood, J. A. Bursill, P. W. Kuchel, and J.
I. Vandenburg. 2003. Solution structure of CnErg1 (Ergtoxin), a HERG
speciﬁc scorpion toxin. FEBS Lett. 539:138–142.
Trudeau, M., J. Warmke, B. Ganetzky, and G. Robertson. 1995. HERG,
a human inward rectiﬁer in the voltage-gated potassium channel family.
Science. 269:92–95.

Smith, G., H.-W. Tsui, E. Newell, X. Jiang, X.-P. Zhu, F. Tsui, and L.
Schlichter. 2002. Functional up-regulation of HERG K1 channels in
neoplastic hematopoietic cells. J. Biol. Chem. 277:18528–18534.

Tseng, G.-N. 2001. IKr: the hERG channel. J. Mol. Cell. Cardiol. 33:835–
849.

Smith, P., T. Baukrowitz, and G. Yellen. 1996. The inward rectiﬁcation
mechanism of the HERG cardiac potassium channel. Nature. 379:833–836.

Tytgat, J., K. Chandy, M. Garcia, G. Gutman, M.-F. Martin-Eauclaire, J.
van der Walt, and L. Possani. 1999. A uniﬁed nomenclature for shortchain peptides isolated from scorpion venoms: a-KTx molecular
subfamilies. Trends Pharmacol. Sci. 20:444–447.

Spector, P., M. Curran, A. Zou, M. Keating, and M. Sanguinetti. 1996. Fast
inactivation causes rectiﬁcation of the IKr channel. J. Gen. Physiol.
107:611–619.
Stocker, M., and C. Miller. 1994. Electrostatic distance geometry in a K1
channel vestibule. Proc. Natl. Acad. Sci. USA. 91:9509–9513.

Ulens, C., and J. Tytgat. 2000. Redox state dependency of HERGS631C
channel pharmacology: relation to C-type inactivation. FEBS Lett.
474:111–115.
Wang, K.-W., K. Tai, and S. Goldstein. 1996. MinK residues line
a potassium channel pore. Neuron. 16:571–577.

Swartz, K., and R. MacKinnon. 1997a. Hanatoxin modiﬁes the gating of
a voltage-dependent K1 channel through multiple binding sites. Neuron.
18:665–673.

Wang, S., M. Morales, S. Liu, H. Strauss, and R. Rasmusson. 1997.
Modulation of HERG afﬁnity for E-4031 by [K1]o and C-type
inactivation. FEBS Lett. 417:43–47.

Swartz, K., and R. MacKinnon. 1997b. Mapping the receptor site for
hanatoxin, a gating modiﬁer of voltage-dependent K1 channels. Neuron.
18:675–682.

Zhou, W., F. Cayabyab, P. Pennefather, L. Schlichter, and T. DeCoursey.
1998. HERG-like K1 channels in microglia. J. Gen. Physiol. 111:781–
794.

Biophysical Journal 84(5) 3022–3036

